BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 11140693)

  • 1. Expression of mouse apolipoprotein SAA1.1 in CE/J mice: isoform-specific effects on amyloidogenesis.
    Yu J; Zhu H; Guo JT; de Beer FC; Kindy MS
    Lab Invest; 2000 Dec; 80(12):1797-806. PubMed ID: 11140693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenoviral expression of murine serum amyloid A proteins to study amyloid fibrillogenesis.
    Kindy MS; King AR; Yu J; Gerardot C; Whitley J; de Beer FC
    Biochem J; 1998 Jun; 332 ( Pt 3)(Pt 3):721-8. PubMed ID: 9620875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid formation in the rat: adenoviral expression of mouse serum amyloid A proteins.
    Yu J; Guo JT; Zhu H; Kindy MS
    Amyloid; 2000 Mar; 7(1):32-40. PubMed ID: 10842703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of SAA and amyloidogenesis in congenic mice of CE/J and C57BL/6 strains.
    Wang L; Liepnieks JJ; Benson MD; Kluve-Beckerman B
    Amyloid; 2000 Mar; 7(1):26-31. PubMed ID: 10842702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AA amyloidosis-resistant CE/J mice have Saa1 and Saa2 genes that encode an identical SAA isoform.
    Mori M; Tiang G; Higuchi K
    Amyloid; 2014 Mar; 21(1):1-8. PubMed ID: 24228751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural prerequisites for serum amyloid A fibril formation.
    de Beer MC; de Beer FC; McCubbin WD; Kay CM; Kindy MS
    J Biol Chem; 1993 Sep; 268(27):20606-12. PubMed ID: 8376413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenic serum amyloid A 1.1 shows a long oligomer-rich fibrillation lag phase contrary to the highly amyloidogenic non-pathogenic SAA2.2.
    Srinivasan S; Patke S; Wang Y; Ye Z; Litt J; Srivastava SK; Lopez MM; Kurouski D; Lednev IK; Kane RS; Colón W
    J Biol Chem; 2013 Jan; 288(4):2744-55. PubMed ID: 23223242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the inbred CE/J mouse strain as amyloid resistant.
    Sipe JD; Carreras I; Gonnerman WA; Cathcart ES; de Beer MC; de Beer FC
    Am J Pathol; 1993 Nov; 143(5):1480-5. PubMed ID: 7901995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of the carboxy terminus of serum amyloid A on protein oligomerization, misfolding, and fibril formation.
    Patke S; Maheshwari R; Litt J; Srinivasan S; Aguilera JJ; Colón W; Kane RS
    Biochemistry; 2012 Apr; 51(14):3092-9. PubMed ID: 22448726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. apo-SAA1/apo-SAA2 isotype ratios during casein- and amyloid-enhancing-factor-induced secondary amyloidosis in A/J and C57BL/6J mice mice.
    Hébert L; Gervais F
    Scand J Immunol; 1990 Feb; 31(2):167-73. PubMed ID: 2309099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From hexamer to amyloid: marginal stability of apolipoprotein SAA2.2 leads to in vitro fibril formation at physiological temperature.
    Wang L; Lashuel HA; Colón W
    Amyloid; 2005 Sep; 12(3):139-48. PubMed ID: 16194868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloidogenesis. One serum amyloid A isotype is selectively removed from the circulation.
    Meek RL; Hoffman JS; Benditt EP
    J Exp Med; 1986 Mar; 163(3):499-510. PubMed ID: 3950541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum amyloid A1 isoforms display different efficacy at Toll-like receptor 2 and formyl peptide receptor 2.
    Chen M; Zhou H; Cheng N; Qian F; Ye RD
    Immunobiology; 2014 Dec; 219(12):916-23. PubMed ID: 25154907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of mouse acute-phase (SAA1.1) and constitutive (SAA4) serum amyloid A isotypes: influence on lipoprotein profiles.
    Kindy MS; de Beer MC; Yu J; de Beer FC
    Arterioscler Thromb Vasc Biol; 2000 Jun; 20(6):1543-50. PubMed ID: 10845870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of individual acute phase serum amyloid A isoforms on HDL metabolism in mice.
    Kim MH; de Beer MC; Wroblewski JM; Charnigo RJ; Ji A; Webb NR; de Beer FC; van der Westhuyzen DR
    J Lipid Res; 2016 Jun; 57(6):969-79. PubMed ID: 27018443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mink serum amyloid A protein. Expression and primary structure based on cDNA sequences.
    Marhaug G; Husby G; Dowton SB
    J Biol Chem; 1990 Jun; 265(17):10049-54. PubMed ID: 2351648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse serum amyloid A protein. Complete amino acid sequence and mRNA analysis of a new isoform.
    de Beer MC; de Beer FC; Beach CM; Carreras I; Sipe JD
    Biochem J; 1992 May; 283 ( Pt 3)(Pt 3):673-8. PubMed ID: 1590757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deficiency of endogenous acute phase serum amyloid A does not affect atherosclerotic lesions in apolipoprotein E-deficient mice.
    De Beer MC; Wroblewski JM; Noffsinger VP; Rateri DL; Howatt DA; Balakrishnan A; Ji A; Shridas P; Thompson JC; van der Westhuyzen DR; Tannock LR; Daugherty A; Webb NR; De Beer FC
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):255-61. PubMed ID: 24265416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential plasma clearance of murine acute-phase serum amyloid A proteins SAA1 and SAA2.
    Kluve-Beckerman B; Yamada T; Hardwick J; Liepnieks JJ; Benson MD
    Biochem J; 1997 Mar; 322 ( Pt 2)(Pt 2):663-9. PubMed ID: 9065791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diversity and complexity of the mouse Saa1 and Saa2 genes.
    Mori M; Tian G; Ishikawa A; Higuchi K
    Exp Anim; 2014; 63(1):99-106. PubMed ID: 24521869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.